Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 12239

Original article / research
Table of Contents - Year : 2018 | Month : June | Volume : 12 | Issue : 6 | Page : DC10 - DC14

Molecular Diversity of Hepatitis B Virus X Gene in Central Kerala, Southern India DC10-DC14

Ozhiparambil A Jagan, Gopi Manoj, Natamai S Jayaprakash, Ramesh M Nair, Sara Chandy

Correspondence
Dr. Sara Chandy,
No. 42, New Tank Street, INCLEN BASIS Project Office, Nungambakkam-600034, Chennai, Tamil Nadu, India.
E-mail: sarachandy@yahoo.co.in

Introduction: Hepatitis B Virus (HBV) causes diverse clinical manifestations ranging from acute fulminant Hepatitis, Chronic Hepatitis (CHB) to liver cirrhosis and Haepatocellular Carcinoma (HCC). The HBV X gene (HBV-X) is a 154 amino acid multifunctional protein, mutates frequently and has a role in HBV related HCC.

Aim: The current study was to explore the genetic variability and identify mutations of HBV-X in CHB patients from Central Kerala, India.

Materials and Methods: The HBV-X sequences (n=39) from CHB (n=90) patients were analysed for nucleotide and amino acid diversity. Phylogenetic analyses were done using MEGA version 7.0.21 software to determine different genotypes.

Results: Basal Core Promoter (BCP) mutations: A1762T/G1764A (n=5) were found in HBeAg negative subjects (n=3, 60%). Bioinformatic analysis showed that the substitutions and mutations were HBV genotype/subgenotype specific. The predominant genotype detected was A1 (n=52, 57.77%) followed by genotype D (n=27, 30.00%). Nucleotide and amino acid diversities were more in genotype A1 than in D, which is responsible for transactivation (p<0.0001), those infected with this genotype may be at high risk for HCC.

Conclusion: Genotype A1 isolates displayed most mutations/substitutions in HBV-X, Further studies are necessary to understand its role in contributing to the development of HCC. The study represents the first formal investigation of HBV-X genetic variability in Kerala.